MedTrace Logo

Metabolism of Low Carbohydrate and Ketogenic Diet

NCT05071287 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-02-21

No results posted yet for this study

Summary

This study will assess the preliminary efficacy of a lifestyle intervention including low-carb/ketogenic diet and exercise, enhanced by self-monitoring through health technologies on weight and diabetes outcomes (Glucose, HbA1c) and diabetic complications (cognitive function, and renal function) in a 6-month randomized clinical trial in 60 overweight/obese adults with or without T2D. Renal function will be assessed via both traditional and novel biomarkers, including novel metabolites and mitochondrial function.

Conditions

  • Diabetic Kidney Disease
  • Cognitive Function
  • Weight Loss
  • Diabetic Control
  • Type2 Diabetes

Interventions

OTHER

mHealth + low-fat diet

A restricted total calorie and reduced total fat consumption.

OTHER

mHealth + low-carb/ketogenic diet

A low-carb/ketogenic diet

Sponsors & Collaborators

  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Yan Du, PhD MPH RN · University of Texas Health San Antonio

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-03
Primary Completion
2022-04-30
Completion
2022-10-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05071287 on ClinicalTrials.gov